Dai et al reported a simple prognostic model for Extranodal NK/T-Cell Lymphoma (ENKTL). This can help to identify a patient who may benefit from more aggressive management. The authors are from the National Cancer Center, Peking Union Medical College and Chinese Academy of Medical Sciences.
Patient selection: Extranodal NK/T-Cell Lymphoma (ENKTL), upper aerodigestive, Stage III or IIE
Parameters:
(1) Ann Arbor stage
(2) serum beta2-microglobulin to lymphocyte ratio index (beta LRI)
(3) serum LDH to lymphocyte index ratio (LLRI)
Parameter
Finding
Points
Ann Arbor stage
1
0
2 to 4
1
betaLRI
<= 4.87
0
> 4.87
1
LLRI
<= 128.44
0
> 128.44
1
total score =
= SUM(points for all 3 parameters)
Interpretation:
• minimum score: 0
• maximum score: 3
Total Score
5-Year Overall Survival
0
90%
1
83.5%
2
63.9%
3
0%
To read more or access our algorithms and calculators, please log in or register.
